GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » cbdMD Inc (AMEX:YCBDPA.PFD) » Definitions » Days Sales Outstanding

cbdMD (YCBDPA.PFD) Days Sales Outstanding : 22.34 (As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is cbdMD Days Sales Outstanding?

cbdMD's average Accounts Receivable for the three months ended in Mar. 2025 was $1.16 Mil. cbdMD's Revenue for the three months ended in Mar. 2025 was $4.75 Mil. Hence, cbdMD's Days Sales Outstanding for the three months ended in Mar. 2025 was 22.34.

The historical rank and industry rank for cbdMD's Days Sales Outstanding or its related term are showing as below:

YCBDPA.PFD' s Days Sales Outstanding Range Over the Past 10 Years
Min: 10.19   Med: 20.61   Max: 1865.95
Current: 18.98

During the past 10 years, cbdMD's highest Days Sales Outstanding was 1865.95. The lowest was 10.19. And the median was 20.61.

YCBDPA.PFD's Days Sales Outstanding is ranked better than
94.57% of 958 companies
in the Drug Manufacturers industry
Industry Median: 72.225 vs YCBDPA.PFD: 18.98

cbdMD's Days Sales Outstanding increased from Mar. 2024 (20.53) to Mar. 2025 (22.34).


cbdMD Days Sales Outstanding Historical Data

The historical data trend for cbdMD's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

cbdMD Days Sales Outstanding Chart

cbdMD Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.54 10.19 13.26 20.14 20.61

cbdMD Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.53 15.73 19.03 20.14 22.34

Competitive Comparison of cbdMD's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, cbdMD's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


cbdMD's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, cbdMD's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where cbdMD's Days Sales Outstanding falls into.


;
;

cbdMD Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

cbdMD's Days Sales Outstanding for the fiscal year that ended in Sep. 2024 is calculated as

Days Sales Outstanding (A: Sep. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2023 ) + Accounts Receivable (A: Sep. 2024 )) / count ) / Revenue (A: Sep. 2024 )*Days in Period
=( (1.216 + 0.984) / 2 ) / 19.482*365
=1.1 / 19.482*365
=20.61

cbdMD's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

Days Sales Outstanding (Q: Mar. 2025 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2024 ) + Accounts Receivable (A: Mar. 2025 )) / count ) / Revenue (A: Mar. 2025 )*Days in Period
=( (1.273 + 1.052) / 2 ) / 4.749*365 / 4
=1.1625 / 4.749*365 / 4
=22.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


cbdMD  (AMEX:YCBDPA.PFD) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


cbdMD Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of cbdMD's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


cbdMD Business Description

Traded in Other Exchanges
Address
2101 Westinghouse Boulevard, Suite A, Charlotte, NC, USA, 28273
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.

cbdMD Headlines

From GuruFocus

Q1 2023 cbdMD Inc Earnings Call Transcript

By GuruFocus Research 02-15-2024

Q1 2020 cbdMD Inc Earnings Call Transcript

By GuruFocus Research 02-15-2024

Q1 2025 cbdMD Inc Earnings Call Transcript

By GuruFocus News 02-14-2025

Q1 2022 cbdMD Inc Earnings Call Transcript

By GuruFocus Research 02-15-2024

Q4 2023 cbdMD Inc Earnings Call Transcript

By GuruFocus Research 02-15-2024

Q4 2021 cbdMD Inc Earnings Call Transcript

By GuruFocus Research 02-15-2024

cbdMD Inc Annual Shareholders Meeting Transcript

By GuruFocus Research 02-15-2024

Q3 2023 cbdMD Inc Earnings Call Transcript

By GuruFocus Research 02-15-2024

cbdMD Inc Annual Shareholders Meeting Transcript

By GuruFocus Research 02-15-2024